Don’t get lost in translation: How smart design and technology are enabling bench-to-bedside in translational research

Abstract only In recent years, cell-based therapies such as immunotherapy have shown very interesting and promising results, most notably in the fields of oncology and tissue regeneration. As researchers in these and other related fields continue to solve increasingly difficult scientific problems,...

Full description

Saved in:
Bibliographic Details
Published in:Science (American Association for the Advancement of Science) 2015-10, Vol.350 (6257), p.223-223
Main Authors: Levine, Bruce, Ramsborg, Chris, Cooper, Laurence J. N.
Format: Article
Language:English
Subjects:
Drugs
Patients
Therapy
Tissue engineering
Translations
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract only In recent years, cell-based therapies such as immunotherapy have shown very interesting and promising results, most notably in the fields of oncology and tissue regeneration. As researchers in these and other related fields continue to solve increasingly difficult scientific problems, they need to prepare for the next step: moving their treatment out of the research lab and into a larger-scale manufacturing environment. This step presents an entirely new set of critical challenges, including workflow management, resource planning, and ensuring the most efficient use of precious patient samples. In this webinar you'll hear from leading professionals who are experienced in both scaling-up (generating more cells per batch) and scaling-out (generating more batches) the production of their “living drugs” in the most effective way possible. The reliability of this process has real-world impacts on patient well-being and survival. View the Webinar
ISSN:0036-8075
1095-9203
DOI:10.1126/science.350.6257.223-c